ArticleFrontiers in neurology2024
Prognostic value of multi-PLD ASL radiomics in acute ischemic stroke.
Article in Frontiers in neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Early prognosis prediction of acute ischemic stroke (AIS) can support clinicians in choosing personalized treatment plans. The aim of this study is to develop a machine learning (ML) model that uses multiple post-labeling delay times (multi-PLD) arterial spin labeling (ASL) radiomics features to achieve early and precise prediction of AIS prognosis. Methods: This study enrolled 102 AIS patients admitted between December 2020 and September 2024. Clinical data, such as age and baseline National Institutes of Health Stroke Scale (NIHSS) score, were collected. Radiomics features were extracted from cerebral blood flow (CBF) images acquired through multi-PLD ASL. Features were selected using least absolute shrinkage and selection operator regression, and three models were developed: a clinical model, a CBF radiomics model, and a combined model, employing eight ML algorithms. Model performance was assessed using receiver operating characteristic curves and decision curve analysis (DCA). Shapley Additive exPlanations was applied to interpret feature contributions. Results: The combined model of extreme gradient boosting demonstrated superior predictive performance, achieving an area under the curve (AUC) of 0.876. Statistical analysis using the DeLong test revealed its significant outperformance compared to both the clinical model (AUC = 0.658, Conclusion: The integration of clinical data and multi-PLD ASL radiomics features in a model offers a secure and dependable approach for predicting the prognosis of AIS, particularly beneficial for patients with contraindications to contrast agents. This model aids clinicians in devising individualized treatment plans, ultimately enhancing patient prognosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.